Lexogen
Lexogen GmbH is a Vienna-based biotechnology company that develops RNA-Seq library preparation kits, NGS sequencing services, and bioinformatics tools for academic researchers, pharmaceutical and biotech firms, and clinical laboratories across more than 50 countries.
- Company typePrivate
- Founded2007
- HeadquartersVienna, Austria
- Headcount101–250
- GTM typeB2B
- OfferingHardware or Manufacturing
What Lexogen does
Lexogen GmbH is a Vienna-headquartered biotechnology company founded in 2007 that develops and commercializes RNA sequencing (RNA-Seq) library preparation kits, reagents, and related next-generation sequencing (NGS) services for transcriptome analysis. Its core technology portfolio spans whole-transcriptome library prep (CORALL), 3' mRNA-Seq expression profiling (QuantSeq), high-definition single-cell 3' mRNA-Seq (LUTHOR), metabolic RNA labeling (SLAMseq), rRNA depletion (RiboCop), small RNA-Seq (miRVEL), and spike-in controls (SIRVs), all produced under ISO 13485 quality standards. The company complements its kit business with full-service NGS offerings — including whole transcriptome, single-cell, FFPE, blood, plant, small RNA, ultra-low input, and DNA sequencing — plus bioinformatics services and the Kangooroo cloud-based data analysis platform.
Lexogen serves academic and research institutions, pharmaceutical and biotechnology companies, and clinical laboratories, with documented engagements including Stanford Medical School, Goethe-University Frankfurt, invIOs GmbH, and Ochre Bio. The business model is hybrid: one-time catalog and quote-based sales of kits and consumables through a direct webshop, email, phone, and fax ordering, combined with usage-based per-sample NGS service pricing and an annual subscription tier for the Kangooroo analytics platform. Commercial reach is global — a wholly-owned US subsidiary (Lexogen, Inc., Greenland, NH) with four regional sales territories, plus a trained distributor network covering more than 50 countries — while strategic partnerships with Cytosurge (Live-seq single-cell), Ochre Bio (human liver functional genomics), and BigOmics Analytics (downstream analytics) extend the technology and data footprint.
Lexogen firmographics
Firmographics- Name
- Lexogen
- Legal name
- Lexogen GmbH
- Website
- https://lexogen.com
- Company type
- Private
- Founded year
- 2007
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- Lexogen GmbH is a Vienna-based biotechnology company that develops RNA-Seq library preparation kits, NGS sequencing services, and bioinformatics tools for academic researchers, pharmaceutical and biotech firms, and clinical laboratories across more than 50 countries.
- Ownership category
- akta.pro rank
Lexogen industry classification
Industry- Product category
- RNA Sequencing Reagents
- NAICS
- In-Vitro Diagnostic Substance Manufacturing (325413), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Scientific Research and Development Services (5417)
- SIC
- Services-Medical Laboratories (8071), In Vitro & In Vivo Diagnostic Substances (2835)
- akta.pro primary industry
- Transcriptomics & Gene Expression Profiling Services (HLAGANAE)
- akta.pro secondary industry
- Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays) (HLAGAIAF)
Keywords
Where Lexogen is headquartered
LocationHeadquarters
- HQ city
- Vienna
- HQ country
- Austria
- HQ region
- Europe
Offices2 records
Markets served
Lexogen business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Technology or R&D, Supply Chain, Operations, Marketing or Sales, Infrastructure
Revenue model
- RNA-Seq Kit Products: Sale of RNA sequencing library preparation kits, reagents, and consumables including CORALL, QuantSeq, LUTHOR, SLAMseq, RiboCop, miRVEL, and related products. Products are sold directly through the online store and through distributors in 50+ countries.
- NGS Services: Comprehensive next-generation sequencing services including gene expression profiling, whole transcriptome sequencing, FFPE RNA sequencing, blood RNA sequencing, plant RNA sequencing, small RNA sequencing, single-cell RNA sequencing, ultra-low input RNA sequencing, DNA sequencing, and custom bioinformatics solutions. Services are priced per sample with project-based quotes.
- Bioinformatics/Data Analysis: Data analysis services including Kangooroo platform access, Lexogen Bioinformatics Service, and custom bioinformatics solutions. Complementary to kit purchases or available as standalone service.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | RNA-Seq Library Prep Kits - Product catalog with catalog numbers available for all products |
| Usage-based | Pay-as-you-go | NGS Services - Per-sample and project-based pricing |
| Subscription | Annual | Kangooroo Data Analysis Platform - Cloud-based analysis for Lexogen kit users |
Go-to-market motion1 record
Distribution channels6 records
Marketing channels11 records
Lexogen product offering
Product offeringCore offering
Lexogen develops and manufactures proprietary RNA sequencing (RNA-Seq) library preparation kits—including CORALL, QuantSeq, LUTHOR, SLAMseq, RiboCop, and miRVEL—and provides end-to-end next-generation sequencing services spanning gene expression profiling, whole transcriptome, single-cell, FFPE, blood, small RNA, and ultra-low input applications. The company also offers the Kangooroo cloud-based data analysis platform and custom bioinformatics solutions for research and drug discovery customers.
Product overview
Lexogen offers an integrated portfolio of RNA analysis solutions comprising library preparation kits and NGS services. The core product lines include CORALL (whole transcriptome), QuantSeq 3' mRNA-Seq (expression profiling), miRVEL (small RNA-Seq), and LUTHOR (single-cell 3' mRNA-Seq) library prep kits. Supporting products include SLAMseq for metabolic labeling, RiboCop rRNA depletion, spike-in controls (SIRVs), RNA extraction/stabilization tools, and cDNA amplification kits. The NGS Services division provides wet lab sequencing services across applications including whole transcriptome, single-cell, FFPE, blood, plant, small RNA, ultra-low input, and drug sequencing, complemented by the Kangooroo cloud-based data analysis platform and custom bioinformatics solutions. Together, these offerings provide end-to-end workflows from sample preparation through data analysis.
Differentiator
Problem solved
Functional benefit
Brands
- Kangooroo: Cloud-based data analysis platform for interactive visualization of expression studies, complementary to Lexogen RNA-Seq kits.
Products and services
- CORALL Total and mRNA-Seq Library Prep Kits Whole transcriptome library preparation kits for total RNA and mRNA sequencing, enabling comprehensive gene expression analysis for academic and pharmaceutical researchers.
- QuantSeq 3' mRNA-Seq Library Prep Kits 3' end-focused mRNA sequencing library prep kits optimized for cost-effective gene expression profiling from various sample types.
- LUTHOR High-Definition Single-Cell 3' mRNA-Seq Single-cell RNA sequencing solution for high-definition 3' mRNA expression profiling at individual cell resolution.
- miRVEL Small RNA-Seq Library Prep Kit Small RNA sequencing library preparation kit for profiling microRNAs and other small non-coding RNAs with improved speed and reproducibility.
- SLAMseq Metabolic RNA Labeling Kit Metabolic RNA labeling kit for time-resolved RNA sequencing to distinguish newly synthesized transcripts and study RNA metabolism and dynamics.
- RiboCop rRNA Depletion Kits Ribosomal RNA depletion kits for removal of rRNA from total RNA samples to enrich for mRNA and non-coding RNAs in NGS workflows.
- SIRVs Spike-In RNA Variant Control Mixes Spike-in RNA variant control mixes used as internal standards in RNA-Seq experiments to monitor technical variability and normalize data.
- Lexogen NGS Services Comprehensive next-generation sequencing services spanning gene expression profiling, whole transcriptome, single-cell, FFPE, blood, plant, small RNA, ultra-low input, high-throughput drug, and DNA sequencing applications for research institutions, pharmaceutical companies, and biotech firms.
- Kangooroo NGS Data Analysis Platform Cloud-based interactive data visualization and analysis platform for expression studies generated with Lexogen RNA-Seq kits, supporting collaborative bioinformatics workflows.
- Lexogen Bioinformatics Service and Custom Bioinformatics Solutions Bioinformatics data analysis service for processing and interpreting NGS data with standard pipelines or tailored custom solutions designed for specific research project requirements.
Quantifiable outcome
- STL001 FOXM1 inhibitor study: Whole transcriptome RNA-Seq using RiboCop rRNA Depletion and CORALL RNA-Seq confirmed mechanism of action and identified novel activities
- +2 more outcomes
Companies that use Lexogen
Customer profileNamed customers3 records
Segments3 records
Ideal customer profiles3 records
Lexogen technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature8 records
Lexogen partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core and secondary.
- Ochre BiocorePartnership to build one of the world's largest human liver functional genomics datasets to date. Lexogen provides NGS services for Ochre Bio's functional genomics research, supporting target identification in drug discovery. The collaboration focuses on advancing human liver research and therapeutic development through high-quality transcriptomic data.
- CytosurgecoreCytosurge launched Live-seq, a single-cell RNA sequencing technology based on FluidFM fluidic force microscopy, developed in collaboration with academic partners. Lexogen provides RNA analysis services for the technology, partnering to offer the service for academic and industry researchers. The partnership enhances Cytosurge's platform performance and market adoption through Lexogen's RNA sequencing expertise.
- BigOmics AnalyticssecondaryLexogen technologies (RiboCop rRNA Depletion and CORALL RNA-Seq) used in research published in collaboration with BigOmics. BigOmics' Omics Playground platform provides advanced data analysis for RNA-Seq experiments. The partnership enables researchers to access integrated wet lab and bioinformatics solutions.
Scale indicators5 records
Recent moves6 records
Expansion highlights5 records
Lexogen competitors and assessment
Company assessmentDirect peers
- Bio-Techne: Bio-Techne (through its RNA-Seq kit portfolio including the formerly exiqon brand) competes directly with Lexogen in RNA library preparation, small RNA analysis, and gene expression profiling reagents sold to academic and pharma researchers.
- Qiagen: Qiagen offers competing NGS library prep kits (e.g., QIAseq) for RNA sequencing, targeted RNA panels, and related sample preparation consumables, making it a direct comparable in research and translational genomics.
- New England Biolabs: NEB provides RNA-Seq library prep kits (e.g., NEBNext) and rRNA depletion reagents that directly overlap with Lexogen's CORALL, QuantSeq, and RiboCop product lines.
- Takara Bio: Takara Bio offers a portfolio of RNA-Seq library prep kits (SMARTer) and single-cell solutions that overlap directly with Lexogen's LUTHOR and whole-transcriptome offerings, particularly in academic and single-cell markets.
- 10x Genomics: 10x Genomics is a leader in single-cell RNA sequencing with Chromium kits; Lexogen's LUTHOR high-definition single-cell 3' mRNA-Seq directly competes for share in single-cell transcriptomics workflows.
Broad incumbents
- Illumina: Illumina is the dominant NGS instrument provider with an expanding library prep and RNA-Seq reagent portfolio; its platform-driven reach and bundled offerings make it a broad incumbent in the same end markets as Lexogen.
- Thermo Fisher Scientific: Thermo Fisher competes through its Ion Torrent and RNA-Seq reagents plus bioinformatics, serving the same research and translational customer base as Lexogen with broader catalog and global reach.
- Revvity (formerly PerkinElmer): Revvity offers genomics reagents and NGS services across academic and clinical research, positioning it as a broader incumbent adjacent to Lexogen's RNA-focused kit and service portfolio.
Emerging players
- Parse Biosciences: Parse Biosciences provides scalable single-cell RNA-Seq solutions (Evercode) targeting translational and academic customers, partially overlapping with Lexogen's single-cell kit and service offerings.
- Olink Holding: Olink provides targeted proteomics and adjacent omics tools used in biomarker and translational research, representing an emerging player in the broader multi-omics workflows where Lexogen's RNA-Seq customers also operate.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Lexogen social profiles
Digital presenceLexogen compliance and trust
Trust signalCompliance1 record
Lexogen financial estimates
Financial estimateRevenue estimate
Valuation estimate
Lexogen leadership team
Management profileNumber of profiles
Profiles2 records
Lexogen subsidiaries and ownership
Company hierarchySubsidiaries1 record
Lexogen funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Lexogen M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Lexogen
What does Lexogen do?
Lexogen develops and manufactures proprietary RNA sequencing (RNA-Seq) library preparation kits—including CORALL, QuantSeq, LUTHOR, SLAMseq, RiboCop, and miRVEL—and provides end-to-end next-generation sequencing services spanning gene expression profiling, whole transcriptome, single-cell, FFPE, blood, small RNA, and ultra-low input applications. The company also offers the Kangooroo cloud-based data analysis platform and custom bioinformatics solutions for research and drug discovery customers.
Is Lexogen a public or private company?
Lexogen is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Lexogen founded?
Lexogen was founded in 2007. It employs 101 to 250 people.
Where is Lexogen based?
Lexogen is headquartered in Vienna, Austria, in the Europe region.
How does Lexogen make money?
Three revenue lines are on record. RNA-Seq Kit Products are the primary driver. The others are NGS Services and bioinformatics/Data Analysis.
Who are Lexogen's main competitors?
Direct peers on record are Bio-Techne, Qiagen, New England Biolabs, Takara Bio and 10x Genomics. Broad incumbents are Illumina, Thermo Fisher Scientific and Revvity (formerly PerkinElmer). Emerging players are Parse Biosciences and Olink Holding.
Does Lexogen have an API?
No public API is recorded for Lexogen.
What industry is Lexogen in?
Lexogen's product category is RNA Sequencing Reagents. Its primary akta.pro industry code is HLAGANAE, Transcriptomics & Gene Expression Profiling Services, with a secondary code of HLAGAIAF, Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays). Its NAICS code is 325413 and its SIC code is 8071.